Innovative research aims to improve the quality of life for those living with spinal cord injuries
There are believed to be around 1.5 million different species of fungus on Earth, but one mold, known as Aspergillus fumigatus, causes the majority of cases of invasive aspergillosis – a devastating illness that kills 90 per cent of patients with weakened immune systems or lung diseases.
A new study led by researchers in Canada sheds light on the effects of off-label use of prescription drugs with the first-ever investigation in adult populations.
Discovery of how environmental memories may be transmitted from a man to his grandchildren
Researchers have discovered how to predict some cardiac arrhythmias several steps before they even occur. It’s a finding that could lead to an improved cardiac device, with equipment designed to detect when arrhythmias are about to occur and then act to prevent them.
Researchers from McGill University and its hospital-affiliated research institutes have been awarded $91.5 million in grants in the latest round of funding by the Canadian Institutes of Health Research (CIHR).
Dr. Ashok Malla and his team leads ACCESS Canada project TRAM- Transformational Research in Adolescent Mental Health. To read more about this five year and 25$ M initiative jointly funded by Canadian Institutes of Health Research (CIHR) and the Graham Boeckh Foundation (GBF), click the following link.
The message below was sent by Mary-Margaret Klempa, Senior Director, OSR regarding Academic salaries paid from Tri Agency grants. This is being widely communicated to ensure that we are in compliance with this regulation. Please read carefully. Take note that while this memo addresses Tri-Agency regulations, it applies to many other granting agencies. Any academic salary support to be charged to restricted research funds should be looked into carefully before finalizing an offer letter and/or processing labor distribution appointment forms.
Please join us in congratulating the recipients of the CIHR operating grants competition. (Posted June 28, 2013) Gabriella Gobbi (Martin Beaulieu) Melatonin MT1 receptor as a target for antidepressant drugs Jorge Armony (Neda Ladbon Bernasconi) Effects of Amygdala Lesions on Human Emotional Processing Véronique Bohbot (John C Breitner, Ridha Joober, Kyoko Konishi) Genetic modulation of Virtual Navigational Strategies, and Brain Function and Grey Matter in Healthy Aging
November 27, 2012 - Clinician-scientists take a unique, integrated approach that is essential to advancing science and medicine. Problems encountered in the clinic inspire research and new findings from the labs are directly applied to patients’ needs. The integrated model is a hallmark of the Montreal Neurological Institute and Hospital – The Neuro, at McGill University and the MUHC and is now being replicated worldwide.
Systemic lupus erythematosus (SLE), commonly known as lupus, is an autoimmune disease in which the body's immune system attacks healthy tissue such as the skin, joints, kidneys and the brain, leading to inflammation and lesions. The disease affects about 1 in 2000 Canadians, particularly women. Previous research has suggested that lupus patients have an increased risk of developing cancer, particularly lymphoma. Lymphoma is a type of blood cancer that occurs when cells called lymphocytes, which usually help protect the body from infection and disease, begin growing and multiplying uncontrollably leading to tumor growth.
Ottawa, Ontario (October 1, 2012) – The Honourable Leona Aglukkaq, Minister of Health, joined Tony Boeckh, Chair of the Graham Boeckh Foundation, and Dr. Alain Beaudet, President of the Canadian Institutes of Health Research (CIHR), to announce the launch of the new Patient-Oriented Network in Adolescent and Youth Mental Health. The research network aims to improve the care provided to young Canadians with mental illness by taking research findings and using them in practice and policy.